Anhidrotic ectodermal dysplasia (EDA) is a rare Xlinked recessive disorder characterized by the absence or hypoplasia of hair, teeth and sweat glands. The gene responsible for the disorder has recently been cloned. The predicted gene product is a 135 amino acid protein with no significant homology to previously known proteins. As a first step to analyze function, we have studied the subcellular localization of the EDA gene product expressed in two epithelial cell lines, COS-1 and MCF-7. Biochemical fractionation and confocal imaging analysis show that, in agreement with a single putative transmembrane domain inferred from its sequence, the EDA protein is transported to the plasma membrane. Moreover, in MCF-7 cells expression of EDA is associated with rounding and detachment of the cells. These results suggest that the EDA protein may be involved in cellular dynamics or signaling.
INTRODUCTION
Anhidrotic ectodermal dysplasia (EDA, MIM305100) is an X-linked recessive disorder which affects ectodermal structures. The phenotype includes absence or hypoplasia of hair, teeth and sweat glands (1) . Additional, less specific symptoms include atopy, hyperpigmentation around the eyes, mild facial dysmorphic features and increased susceptibility to respiratory infections (1, 2) . The phenotype is seen in its full form only in affected males, where a major clinical problem is regulation of body temperature in the absence of sweating.
The gene responsible for the disorder has recently been isolated by positional cloning (3) . Localization of translocation breakpoints in female EDA patients together with the detection of large molecular deletions and rearrangements in male patients facilitated fine mapping of the gene (4) (5) (6) (7) (8) (9) . Additional point mutations were found in several EDA patients in the newly isolated gene (3) .
More than 150 clinically distinct ectodermal dysplasias are known (10) and so far EDA is the only disorder for which the responsible gene has been isolated. Studies of the gene structure and function could help to further understand the molecular mechanisms involved in the development of ectodermal structures. EDA encodes a 135 amino acid protein without any significant homology to previously known proteins; a putative transmembrane domain in the sequence suggests that it is an integral membrane protein. Since the development of all the structures affected in EDA requires ectoderm-mesoderm interactions (11, 12) , EDA could participate in signaling processes that determine the development of ectodermal appendices.
As a first step in elucidating the cellular function of EDA, we have produced polyclonal antibodies and used them to analyze the subcellular localization of EDA protein formed after transfection into monkey kidney COS-1 cells and human breast carcinoma MCF-7 cells. The results show that the EDA protein is associated with the cell membrane and that it may participate in the regulation of cell-cell or cell-matrix interactions.
RESULTS

Expression of EDA in COS-1 cells
EDA cDNA was cloned into a mammalian expression vector pCMV5 and transiently expressed in COS-1 cells. The cDNA contains two possible alternate ATG codons separated by five amino acids, resulting in peptides with calculated molecular weights of 14 and 14.5 kDa (Fig. 1) .
Using polyclonal antibodies (see Materials and Methods) no signal is detected in Western blots of total lysates of cells transfected with the pCMV5 vector alone, while in EDA-transfected cells the anti-EDA antibodies recognize two closely migrating bands at ∼15 and 18 kDa (Fig. 2a) . No signal is detectable in culture medium. The specificity of the signal was confirmed by blocking the reaction with addition of the antigen, bacterial GST-EDA fusion protein. No signal is seen in the pre-immune serum control (Fig. 2a) .
The lower band detected in the transfected cells co-migrates with bacterially expressed EDA protein (Fig. 2b) . Hence, it is *To whom correspondence should be addressed. Tel: +35 89 1912 6538; Fax: +35 89 1912 6677; Email: juha.kere@helsinki.fi Figure 1 . Schematic structure of the EDA protein. Two ATG codons in the cDNA result in alternative 140 or 135 amino acid products. In the genomic sequence, however, the first ATG codon is replaced by GTG, resulting in only the 135 amino acid product. A putative transmembrane domain is found at residues 40-61 (dashed box). The EDA protein has been suggested to belong to the type II class of membrane proteins, e.g. C-terminus protruding to the extracellular space, based on lack of signal peptide and a weak homology to membrane-associated collagen-like proteins (3) . No apparent N-glycosylation sites are found in the sequence. Immunoblot of culture medium (M) and total cell lysates (C) from COS-1 cells transfected with EDA cDNA (+) and with vector CMV5 alone (-). The blots were reacted with pre-immune serum or with anti-EDA antibodies. EDA protein is detected as two closely migrating bands with apparent molecular weights of 15 and 18 kDa (arrows). The reaction is blocked by addition of specific antigen, bacterial GST-EDA fusion protein, at 10× molar excess (+GST-EDA), but not by addition of vector-derived GST protein (+GST). (b) Immunoblot of bacterially expressed EDA protein (E.coli) and total cell lysate from EDA transfected COS-1 cells reacted with anti-EDA antibodies. The bacterial product is 138 amino acids (three amino acids from GST protein followed by 135 amino acids of the EDA protein) and it lacks post-translational modifications. The lower band detected in the COS-1 cell lysate (COS) co-migrates with the bacterial product.
likely that the two possible alternate 135 and 140 amino acid products co-migrate in the lower band seen in COS-1 cells and that the upper band represents a post-translationally modified EDA protein product.
EDA is membrane associated
To initially determine the subcellular localization of the EDA protein, subcellular fractions were prepared from transfected COS-1 cells. Nuclei were pelleted from the cell homogenate and the post-nuclear fraction was further separated into insoluble and soluble fractions. The insoluble P30 fraction contains heavier membrane fragments, mitochondria and remaining nuclei, whereas the P100 fraction contains lighter membranes, mainly smaller vesicles and microsomes. The fractions were run on SDS-polyacrylamide gels and reacted with anti-EDA antibodies. EDA protein is detected in the insoluble P30 and P100 fractions, while no detectable amount is found in the nuclear or soluble cytoplasmic fractions (Fig. 3) . As a control, the fractions were reacted with antibodies against actin, the signal for which is detected, as expected, mainly in the soluble fraction (Fig. 3) .
EDA is found both in intracellular and plasma membranes
To further define the subcellular localization of the protein, we combined confocal laser scanning microscopy with immunofluorescence staining of the COS-1 cells transiently transfected with EDA. In cells permeabilized with Triton X-100 and stained with anti-EDA antibodies some cells show a weak intracellular signal with a netlike pattern, while other cells show a clear staining of the cell membrane (Fig. 4a ). Double labeling with a marker for endoplasmic reticulum (ER) shows that the intracellular signal is due to staining of ER (Fig. 4b) . The localization of the outer membrane signal is confirmed by double labeling with filamentous actin, where the staining for EDA can be seen to overlap partially with membranal cytoskeleton ( cells ( Fig. 4b and d) , neither with pre-immune serum (Fig. 4e ) nor in cells transfected with the vector only (data not shown). When the Triton X-100 permeabilization step is omitted, the antibodies stain the outer cell surface (Fig. 4f) , implying that part of the EDA protein is found outside the cell.
The staining of the ER could be due to molecules that are being processed for translocation to the outer cell membrane. To test this hypothesis, transfected COS-1 cells were treated with the protein synthesis inhibitor cycloheximide for 3 and 20 h at a concentration of 20 µg/ml prior to staining with anti-EDA antibodies. No significant change was seen in the staining pattern or in the ratio of cells with staining in ER to staining in the plasma membrane (data not shown).
In addition to monkey kidney COS-1 cells, we studied the subcellular localization in transfected human MCF-7 cells. The localization pattern was very similar to COS-1 cells, part of the transfected cells showing strong signal in the cell border and others weaker staining of the ER (Fig. 4g) . Likewise, staining was detected also in the surface of non-permeabilized cells (Fig. 4h) .
In MCF-7 cells expression of EDA is associated with rounding of the cells
Whereas in EDA-transfected COS-1 cells there were no readily noticeable changes in cell morphology, EDA expression in MCF-7 cells was associated with rounding of the cells. More than 80% of the transfected cells with plasma membrane-associated EDA clearly rounded up compared with the normal flat adherent habit of non-transfected MCF-7 cells (Fig. 5) . Round cells were also found among non-transfected cells, but their frequency was <10%. Since most of the cells with EDA localized to ER have an epithelial phenotype, the cell rounding seems not to be induced by transfection and expression of EDA itself, but by association of EDA protein with the cell membrane.
The change in cell shape is seen most sharply by confocal laser scanning microscope analysis of cells doubly stained for EDA and filamentous actin (Fig. 6) . Round EDA-transfected cells (Fig.  6a ) scanned at their base are no longer flattened to the surface like the surrounding non-transfected cells (Fig. 6b) . The cells also lack the long actin filaments seen in non-transfected adherent cells (Fig. 6c) . Adherent contact to the adjacent cells is lost, but many rounded cells are still attached to the monolayer 72 h after transfection (Fig. 6d) .
Contraction and detachment from surrounding cells, accompanied by chromosomal condensation and fragmentation, are also characteristics of apoptosis (13, 14) . The transfected rounded MCF-7 cells were negative in a fluorescein TUNEL (TdT-mediated dUTP nick-end-labeling) assay, which detects fragmented DNA of apoptotic cells (Fig. 7a-c) . Some positive cells were seen among the non-transfected cells (Fig. 7d-f) . Apoptosis may also occur in the absence of DNA fragmentation (14) and it is known that serum-deprived MCF-7 cells show some characteristics of cell death without DNA fragmentation (15) . However, serum deprivation causes rapid detachment with the appearance of pyknotic nuclei (15), characteristics not found in transfected MCF-7 cells. Thus the possibility of apoptosis as the cause of the morphological change is unlikely.
DISCUSSION
Cloning of the EDA gene revealed a small protein with no strong homology to previously known molecules. This provides a challenge to functional investigations. The sequence of a hydrophobic segment was a clue for subcellular localization and we initiated functional studies by looking for a putative membrane association. Polyclonal antibodies to bacterially expressed EDA protein recognize EDA protein expressed in vitro in COS-1 and MCF-7 cells, both in Western blots and in immunocytochemical stainings. No endogenous EDA protein was detected in Western blots, implying that the expression level is very low or negligible.
Western blotting of COS-1 cells detected two closely migrating bands of approximately the expected size, with apparent molecular weights of 15 and 18 kDa. The lower band co-migrates with the bacterially expressed 138 amino acid product, which lacks post-translational modifications. Hence, the upper band may result from a post-translational modification event.
Glycosylation is known to occur on most cell surface membrane proteins. No apparent N-glycosylation sites were found in the EDA sequence, but EDA could have O-linked sugar residues.
In biochemical subcellular fractionation experiments the EDA protein was found in the insoluble P30 and P100 fractions, consistent with association of the protein with membrane. Immunofluorescence studies combined with confocal imaging demonstrated the localization. Signal was also detected on membranes at the surface of non-permeabilized cells, indicating that EDA is a transmembrane protein spanning the cell membrane. However, some cells showed alternative intracellular, reticular staining around the nucleus. By double labeling experiments this signal was shown to co-localize for the most part with ER. Although it cannot be ruled out that EDA also has a function associated with intracellular membranes, it is more likely that the staining is due to molecules that are being processed in the ER for translocation to the cell membrane. To test this hypothesis, cells were treated with a protein synthesis inhibitor. No significant change was seen in the staining pattern, but the extremely high level of expression could explain inefficient translocation of all the synthesized molecules.
A first hint of a possible functional role for EDA protein comes from the production of rounded, detached MCF-7 cells. In contrast to MCF-7 cells, in COS-1 cells there were no clearly notable changes in cell morphology. This could indicate that the COS-1 cells derived from monkey kidney are missing some factors, possibly interacting with EDA, that are found in human breast carcinoma MCF-7 cells.
There are various possible speculative functions for the membrane protein EDA compatible with its requirement in ectodermal organogenesis. EDA could be involved in signal transduction as a membrane-bound messenger, like the ligands for tumor necrosis factor receptors, which are also small integral type II membrane proteins with a single transmembrane domain (16) . Since the phenotypic changes seen in MCF-7 cells were cell autonomous, if EDA is a signaling molecule it is probably working in an autocrine fashion. EDA could also function as a co-receptor in a heteromeric signaling receptor complex or in cellular adhesion, either through interaction with other membrane proteins or through molecules in the extracellular matrix. Various other membrane and membrane-associated proteins, such as receptors for various growth factors and components of the cytoskeleton and the extracellular matrix, have been implicated in ectodermal differentiation (11, 12, 17, 18) and it would be interesting to see whether EDA can interact with any of these molecules.
Several lines of evidence point to a possible interaction between EDA and the pathway of epidermal growth factor (EGF). The phenotype of the mouse mutant Tabby (Ta), which has been postulated to be the mouse homolog of EDA, can be partly reversed by injecting newborn mice with EGF (19) . In addition, fibroblasts from EDA patients and Ta mice have been shown to have reduced levels of epidermal growth factor receptor (EGFR) (20) . EGFR has been shown to interact directly with β-catenin (21), a molecule involved both in cell adhesion and signal transduction (22) . The promoter of EDA contains a putative binding site for lymphoid enhancer factor 1 (LEF 1) (3). LEF 1 is needed for proper tooth and hair development (23) and has been shown recently to be involved in signal transduction through direct interaction with β-catenin (24, 25) . Thus, EDA could interact in some way with the EGFR-catenin-cadherin complex.
In summary, we have shown that the product of the EDA gene is a transmembrane protein localized in the plasma membrane. The antibodies and the expression system described here provide useful tools for the analysis of normal and pathogenetic gene function and will also enable in vitro studies of possible interactions between EDA and other molecules involved in ectodermal differentiation. Since EDA is implicated at an early step in the lineage of ectoderm and its appendages, effects on cell shape and detachment are intriguing. EDA could be involved in regulation of cell-cell or cell-matrix interactions during the migration and movement associated with differentiation.
MATERIALS AND METHODS
Production of affinity purified polyclonal antibodies
The 135 amino acid polypeptide encoded by the EDA cDNA clone 27G4 starting from the second alternative ATG codon ( Fig. 1) was cloned in-frame with the C-terminus of bacterial glutathione S-transferase (GST) in the pGEX-2T plasmid vector (Pharmacia Biotech). The fusion product was expressed in Escherichia coli and the recombinant protein of the expected size, 42 kDa, was purified either using glutathione-agarose beads (Sigma), to yield a native product (N-EDA), or by electroeluting from a SDS-polyacrylamide gel, to yield a denatured product (D-EDA). Polyclonal antisera were generated by immunizing rabbits with each product. Antisera were precleared with a column of GST-glutathione-agarose to remove the GST-specific antibodies and then affinity purified with the bacterial GST-nEDA antigen bound to an Affi-Gel 10 gel column (BioRad), according to the manufacturer's instructions.
Both antibodies, anti-N-EDA and anti-D-EDA, recognize the EDA protein expressed in vitro in COS-1 and MCF-7 cells in Western blots and immunocytochemical staining.
Transient expression
EDA cDNA was cloned into pCMV-5, a mammalian expression vector from the pCMV series, which utilizes the human cytomegalovirus major immediate early gene promoter. pCMV5 was made by deleting the HpaI-EcoRI segment from the SV40 origin region of pCMV-1 (26) . The cDNA contains two alternative ATG start codons encoding for 140 and 135 amino acid products respectively (3). The cDNA was transiently expressed in COS-1 or MCF-7 cells using Lipofectin (Gibco BRL Life Technologies Inc.) as the transfection agent. Transfection was performed according to the manufacturer's instructions and the cells were harvested or stained 48 h post-transfection, unless otherwise indicated.
COS-1 cells (SV40-transformed African green monkey kidney cells) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. MCF-7 cells (human breast carcinoma cells) were grown in RPM I-1640 medium supplemented with 10% fetal calf serum.
Western blots
SDS-PAGE and Western blotting were carried out according to standard procedures (27) . The primary antibodies were used at the following concentrations; anti-D-EDA antibodies 40 ng/ml and rabbit anti-actin antibodies (Sigma) 5 µg/ml. In antigen blocking experiments bacterial GST-EDA was added at 250 ng/ml and GST at 400 ng/ml. Horseradish peroxidase-conjugated anti-rabbit IgG (Sigma) was used as secondary antibody and detection used enhanced chemiluminescence with reagents from Sigma. The molecular weight markers used were Kaleidoscope prestained standards (BioRad).
Subcellular fractions were prepared from a 100 mm plate of transfected cells as follows. The cells were washed and scraped into cold phosphate-buffered saline (PBS) and pelleted. The pellet was resuspended in 1 ml homogenization buffer (10 mM Tris, pH 7.5, 1 mM EDTA, 3 mM CaCl 2 , 1 mM PMSF) and left on ice for 15 min. Cells were lysed by 40 strokes of a dounce homogenizer and nuclei pelleted at 650 g for 4 min. The supernatant was kept for further fractionation and the nuclear pellet was resuspended in 1% NP-40/homogenization buffer, left on ice for 5 min and pelleted again at 650 g for 4 min.
The post-nuclear supernatant was centrifuged at 30 000 g for 30 min at 4_C. The pellet (P30) was solubilized in homogenization buffer and the supernatant was further separated into insoluble P100 and soluble fractions by centrifugation at 100 000 g for 30 min at 4_C. Aliquots of 30 µg from each fraction were run on SDS-polyacrylamide gels.
Bacterial EDA protein used as a control was prepared from the GST-EDA fusion protein by thrombin digestion.
Confocal imaging
Cells were plated onto glass coverslips in culture dishes and transfected. The cells were rinsed with PBS (0.01 M phosphate salts, 0.15 M NaCl, pH 7.5) and fixed in 4% paraformaldehyde/PBS at room temperature for 5 min, then washed and permeabilized with 0.2% Triton X-100/PBS for 5 min. The Triton X-100 treatment was omitted for non-permeabilized samples. Cells were blocked with PBS containing 3% bovine serum albumin (BSA) for 30 min and then incubated for 45 min at room temperature with primary antibody in 3% BSA/PBS, anti-N-EDA antibodies at 1 µg/ml and the 1D3 supernatant at a 1:10 dilution. The monoclonal 1D3 antibodies, which recognize two proteins (PDI and crp 55) retained in the ER (28), were kindly provided by Dr S.Fuller. After washes with PBS, the samples were incubated for 45 min with secondary antibody, FITC-conjugated goat anti-rabbit IgG (Sigma) or TRITC-conjugated anti-mouse IgG (Sigma) in 3% BSA/PBS. Double labelings were performed in sequential steps. After immunostaining, filamentous actin was stained with phalloidin-TRITC (0.77 µM in PBS, prepared fresh) for 10 min at room temperature and nucleic acids were counterstained with propidium iodide (1 µg/ml in PBS) for 15 min at room temperature. Negative controls included no primary antibody and pre-immune serum. Staining with anti-N-EDA antibody was completely blocked by addition of soluble antigen, the bacterial GST-EDA fusion protein, at 5 µg/ml, but not by addition of bacterial GST protein. In double staining experiments cross-reaction was excluded by appropriate negative controls: no primary antibody, anti-N-EDA followed by TRITC-conjugated anti-mouse IgG, and 1D3 supernatant followed by FITCconjugated goat anti-rabbit IgG. Anti-D-EDA antibodies, which gave the same staining pattern as anti-N-EDA antibodies, were used as a positive control.
Following immunostaining, samples were rinsed briefly with water and mounted in Vectashield mounting medium (Vector laboratories) and imaged with a LSM 410 Laserscan microscope (Zeiss) using excitation wavelengths of 488 and 543 nm.
Detection of apoptosis
To study apoptosis, transfected cells were stained with Apoptosis Detection System, Fluorescein (Promega) according to the manufacturer's instructions, then incubated with anti-D-EDA antibodies followed by TRITC-conjugated anti-rabbit-IgG secondary antibody (Sigma). Cells were counterstained with 4,6-diamino-2-phenylindole (DAPI) to visualize the nuclei and examined with a Leitz Laborlux D fluorescent microscope.
